
Roy R. Teller
Examiner (ID: 12058, Phone: (571)272-0971 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675, 1653 |
| Total Applications | 671 |
| Issued Applications | 374 |
| Pending Applications | 45 |
| Abandoned Applications | 251 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6499085
[patent_doc_number] => 20100215574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'PROCESS FOR PRODUCING AN INJECTABLE MEDICAMENT PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/604093
[patent_app_country] => US
[patent_app_date] => 2009-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7025
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215574.pdf
[firstpage_image] =>[orig_patent_app_number] => 12604093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/604093 | Process for producing an injectable medicament preparation | Oct 21, 2009 | Issued |
Array
(
[id] => 6618633
[patent_doc_number] => 20100099851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'SYNTHETIC HYPERGLYCOSYLATED, PROTEASE-RESISTANT POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/581723
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 118153
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099851.pdf
[firstpage_image] =>[orig_patent_app_number] => 12581723
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/581723 | SYNTHETIC HYPERGLYCOSYLATED, PROTEASE-RESISTANT POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME | Oct 18, 2009 | Abandoned |
Array
(
[id] => 6425812
[patent_doc_number] => 20100168152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Fat regulation'
[patent_app_type] => utility
[patent_app_number] => 12/589229
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19624
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168152.pdf
[firstpage_image] =>[orig_patent_app_number] => 12589229
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/589229 | Fat regulation | Oct 18, 2009 | Issued |
Array
(
[id] => 8689940
[patent_doc_number] => 08389467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'In situ self-setting mineral-polymer hybrid materials, composition and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/575765
[patent_app_country] => US
[patent_app_date] => 2009-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17294
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12575765
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/575765 | In situ self-setting mineral-polymer hybrid materials, composition and use thereof | Oct 7, 2009 | Issued |
Array
(
[id] => 8282904
[patent_doc_number] => 08217006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Inhibiting GS-FDH to modulate no bioactivity'
[patent_app_type] => utility
[patent_app_number] => 12/566006
[patent_app_country] => US
[patent_app_date] => 2009-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9513
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12566006
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/566006 | Inhibiting GS-FDH to modulate no bioactivity | Sep 23, 2009 | Issued |
Array
(
[id] => 8290377
[patent_doc_number] => 20120178700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'PEPTIDOMIMETIC MACROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 13/120360
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27808
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120360
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120360 | PEPTIDOMIMETIC MACROCYCLES | Sep 21, 2009 | Abandoned |
Array
(
[id] => 6480330
[patent_doc_number] => 20100092539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Fluorinated GHRH Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/562096
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27680
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092539.pdf
[firstpage_image] =>[orig_patent_app_number] => 12562096
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/562096 | Fluorinated GHRH antagonists | Sep 16, 2009 | Issued |
Array
(
[id] => 9703862
[patent_doc_number] => 08828923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Insulin derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/560833
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18567
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12560833
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/560833 | Insulin derivatives | Sep 15, 2009 | Issued |
Array
(
[id] => 6025761
[patent_doc_number] => 20110053832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'NATURAL ANTIMICROBIAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/553438
[patent_app_country] => US
[patent_app_date] => 2009-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3749
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053832.pdf
[firstpage_image] =>[orig_patent_app_number] => 12553438
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/553438 | NATURAL ANTIMICROBIAL COMPOSITION | Sep 2, 2009 | Abandoned |
Array
(
[id] => 6358898
[patent_doc_number] => 20100087359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'USE OF TRYPTOPHAN RICH PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/550007
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2951
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12550007
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550007 | USE OF TRYPTOPHAN RICH PEPTIDES | Aug 27, 2009 | Abandoned |
Array
(
[id] => 6220643
[patent_doc_number] => 20100055738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Method for Making Acylated Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/543027
[patent_app_country] => US
[patent_app_date] => 2009-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9248
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055738.pdf
[firstpage_image] =>[orig_patent_app_number] => 12543027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543027 | Method for making acylated polypeptides | Aug 17, 2009 | Issued |
Array
(
[id] => 6428425
[patent_doc_number] => 20100168383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Skin or Hair Binding Peptides'
[patent_app_type] => utility
[patent_app_number] => 12/534695
[patent_app_country] => US
[patent_app_date] => 2009-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6540
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168383.pdf
[firstpage_image] =>[orig_patent_app_number] => 12534695
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/534695 | Skin or hair binding peptides | Aug 2, 2009 | Issued |
Array
(
[id] => 6351065
[patent_doc_number] => 20100331236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'CYCLIC PEPTIDES AS G-PROTEIN COUPLED RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/502937
[patent_app_country] => US
[patent_app_date] => 2009-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20807
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502937
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502937 | CYCLIC PEPTIDES AS G-PROTEIN COUPLED RECEPTOR ANTAGONISTS | Jul 13, 2009 | Abandoned |
Array
(
[id] => 6251812
[patent_doc_number] => 20100028317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators'
[patent_app_type] => utility
[patent_app_number] => 12/489619
[patent_app_country] => US
[patent_app_date] => 2009-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13402
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028317.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489619
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489619 | Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators | Jun 22, 2009 | Issued |
Array
(
[id] => 5987709
[patent_doc_number] => 20110098446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Use of a tetraphenylborate (TPB) salt for the separation of biomolecules'
[patent_app_type] => utility
[patent_app_number] => 12/999033
[patent_app_country] => US
[patent_app_date] => 2009-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9580
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098446.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999033
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999033 | Use of a tetraphenylborate (TPB) salt for the separation of biomolecules | Jun 16, 2009 | Issued |
Array
(
[id] => 9964306
[patent_doc_number] => 09011914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Hetero-assembled hydrogels'
[patent_app_type] => utility
[patent_app_number] => 12/455996
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 8531
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12455996
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/455996 | Hetero-assembled hydrogels | Jun 8, 2009 | Issued |
Array
(
[id] => 5404470
[patent_doc_number] => 20090239784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Stablised Insulin Compositions'
[patent_app_type] => utility
[patent_app_number] => 12/476712
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5732
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239784.pdf
[firstpage_image] =>[orig_patent_app_number] => 12476712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476712 | Stablised Insulin Compositions | Jun 1, 2009 | Abandoned |
Array
(
[id] => 5403496
[patent_doc_number] => 20090238810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'OPHTHALMIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/471692
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8329
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238810.pdf
[firstpage_image] =>[orig_patent_app_number] => 12471692
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471692 | OPHTHALMIC COMPOSITION | May 25, 2009 | Abandoned |
Array
(
[id] => 4644428
[patent_doc_number] => 08022033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Echinocandin/carbohydrate complexes'
[patent_app_type] => utility
[patent_app_number] => 12/469724
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10728
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12469724
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/469724 | Echinocandin/carbohydrate complexes | May 20, 2009 | Issued |
Array
(
[id] => 8189258
[patent_doc_number] => 08183210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Reconstituted surfactants having improved properties'
[patent_app_type] => utility
[patent_app_number] => 12/422581
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5624
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183210.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422581 | Reconstituted surfactants having improved properties | Apr 12, 2009 | Issued |